rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2000-11-6
|
pubmed:abstractText |
To assess the effectiveness of palladium-103 brachytherapy in stage T1 and T2 adenocarcinoma of the prostate.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0892-7790
|
pubmed:author |
pubmed-author:BeharR JRJ,
pubmed-author:CantorAA,
pubmed-author:ChovnickS DSD,
pubmed-author:DonohueMM,
pubmed-author:HuffWW,
pubmed-author:OtheguyJJ,
pubmed-author:PerezRR,
pubmed-author:RabinowitzRR,
pubmed-author:SharkeyJJ,
pubmed-author:SolaXX,
pubmed-author:SteeleJJ,
pubmed-author:WebsterCC
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
343-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10910150-Adenocarcinoma,
pubmed-meshheading:10910150-Aged,
pubmed-meshheading:10910150-Aged, 80 and over,
pubmed-meshheading:10910150-Androgen Antagonists,
pubmed-meshheading:10910150-Antineoplastic Agents, Hormonal,
pubmed-meshheading:10910150-Biopsy,
pubmed-meshheading:10910150-Brachytherapy,
pubmed-meshheading:10910150-Combined Modality Therapy,
pubmed-meshheading:10910150-Flutamide,
pubmed-meshheading:10910150-Humans,
pubmed-meshheading:10910150-Leuprolide,
pubmed-meshheading:10910150-Male,
pubmed-meshheading:10910150-Middle Aged,
pubmed-meshheading:10910150-Palladium,
pubmed-meshheading:10910150-Prostate,
pubmed-meshheading:10910150-Prostate-Specific Antigen,
pubmed-meshheading:10910150-Prostatic Neoplasms,
pubmed-meshheading:10910150-Radioisotopes
|
pubmed:year |
2000
|
pubmed:articleTitle |
Minimally invasive treatment for localized adenocarcinoma of the prostate: review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy.
|
pubmed:affiliation |
Urology Health Center, New Port Richey, Florida, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|